UY30096A1 - Imidazoles sustituidos - Google Patents

Imidazoles sustituidos

Info

Publication number
UY30096A1
UY30096A1 UY30096A UY30096A UY30096A1 UY 30096 A1 UY30096 A1 UY 30096A1 UY 30096 A UY30096 A UY 30096A UY 30096 A UY30096 A UY 30096A UY 30096 A1 UY30096 A1 UY 30096A1
Authority
UY
Uruguay
Prior art keywords
imidazols
replaced
substituted
compounds
parasiticides
Prior art date
Application number
UY30096A
Other languages
English (en)
Inventor
Christelle Lauret
Richard Andrew Ewin
Jerome Sebastien Dauvergne
Mark Roger Cox
Nathan Anthony Logan Chubb
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Publication of UY30096A1 publication Critical patent/UY30096A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Esta invención se refiere a una gama de compuestos de imidazol 2-bencil sustituido alfa sustituido y las sales y los solvatos farmacéuticamente aceptables de los mismos, a composiciones que comprenden tales compuestos, procedimientos para sus síntesis y su uso como parasiticidas,
UY30096A 2006-01-19 2007-01-17 Imidazoles sustituidos UY30096A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76076506P 2006-01-19 2006-01-19

Publications (1)

Publication Number Publication Date
UY30096A1 true UY30096A1 (es) 2007-08-31

Family

ID=38038547

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30096A UY30096A1 (es) 2006-01-19 2007-01-17 Imidazoles sustituidos

Country Status (32)

Country Link
US (4) US7592362B2 (es)
EP (2) EP1981853B1 (es)
JP (1) JP4463317B2 (es)
KR (1) KR101044494B1 (es)
CN (1) CN101370786B (es)
AR (1) AR059055A1 (es)
AT (1) ATE505461T1 (es)
AU (1) AU2007206698B2 (es)
BR (1) BRPI0707185B8 (es)
CA (1) CA2632771C (es)
CY (1) CY1111473T1 (es)
DE (1) DE602007013869D1 (es)
DK (1) DK1981853T3 (es)
EA (1) EA015738B1 (es)
ES (1) ES2362935T3 (es)
HK (1) HK1127919A1 (es)
IL (1) IL192063A0 (es)
MA (1) MA30166B1 (es)
ME (2) ME00044B (es)
MY (1) MY145812A (es)
NO (1) NO341141B1 (es)
NZ (1) NZ569209A (es)
PL (1) PL1981853T3 (es)
PT (1) PT1981853E (es)
RS (1) RS53512B1 (es)
SI (1) SI1981853T1 (es)
TN (1) TNSN08306A1 (es)
TW (1) TWI337998B (es)
UA (1) UA93696C2 (es)
UY (1) UY30096A1 (es)
WO (1) WO2007083207A1 (es)
ZA (1) ZA200805565B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01004337A (es) 1998-11-02 2002-04-24 Pont Dow Elastomers L L C Du Interpolimeros de alfa-olefina/etileno que disminuyen el esfuerzo cortante.
US7592362B2 (en) * 2006-01-19 2009-09-22 Pfizer Limited Substituted imidazoles
US20100041712A1 (en) * 2008-08-18 2010-02-18 Pfizer Inc. Substituted imidazole combinations
AU2009331253B2 (en) 2008-12-24 2012-03-08 Daiichi Sankyo Company, Limited Indanyl compounds
SG172140A1 (en) 2008-12-24 2011-07-28 Daiichi Sankyo Co Ltd Cyclic amine compounds
MX2011008816A (es) * 2009-02-23 2011-09-15 Wyeth Llc Formulacion ectoparasiticida con esencia mejorada.
KR101751085B1 (ko) * 2009-07-16 2017-07-11 솔베이 플루오르 게엠베하 플루오로알킬 (플루오로)알킬 카보네이트의 제조 방법
AU2010339691B2 (en) * 2010-01-07 2015-04-02 Alkermes Pharma Ireland Limited Prodrugs of heteraromatic compounds
MX2012008799A (es) 2010-01-29 2012-08-23 Pfizer Formulaciones antiparasitarias topicas.
CN102127066B (zh) * 2010-12-10 2013-08-14 邵阳学院 4-(7-甲氧基-2,2-二甲基-2,3-二氢苯并呋喃-5-基)-2-(3,4-二甲苯氨基)噻唑手性晶体
WO2012139010A1 (en) * 2011-04-08 2012-10-11 University Of Kansas Grp94 inhibitors
US9295623B2 (en) * 2011-10-03 2016-03-29 Eq Ag Solutions Methods of preventing the transmission of communicable diseases in livestock
US9173404B2 (en) 2011-11-17 2015-11-03 Merial, Inc. Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof
SG11201403980VA (en) * 2012-01-13 2014-08-28 Gen Hospital Corp Anesthetic compounds and related methods of use
CN102987824A (zh) * 2012-11-29 2013-03-27 张敏 一种防螨虫被
CN104844459B (zh) * 2014-02-18 2016-08-24 扬州三友合成化工有限公司 一种氯甲基异丙基碳酸酯的制备方法
WO2017087218A1 (en) * 2015-11-18 2017-05-26 Monsanto Technology Llc Insecticidal compositions and methods
US10550089B2 (en) 2016-05-12 2020-02-04 Heptares Therapeutics Limited Inhibitors of protease-activated receptor-2
US10766866B2 (en) 2017-10-30 2020-09-08 University Of North Texas Health Science Center At Fort Worth Deterrents for arthropods and marine organisms
CN115073298A (zh) * 2022-05-31 2022-09-20 湖南华腾制药有限公司 连续流微反应器合成2-甲基-3-三氟甲基苯胺的方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678775A (en) * 1984-05-01 1987-07-07 Nathanson James A Method of controlling pests
FR2613720B1 (fr) * 1987-04-10 1990-01-19 Esteve Labor Dr Derives d'aryl-heteroaryl carbinols avec activite analgesique
SU1655293A3 (ru) * 1987-04-21 1991-06-07 Басф Аг (Фирма) Средство дл борьбы с насекомыми
ZA911217B (en) * 1990-06-29 1991-11-27 Sumitomo Chemical Co A 1-phenylimidazole derivative and its production and use
US5480883A (en) * 1991-05-10 1996-01-02 Rhone-Poulenc Rorer Pharmaceuticals Inc. Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
FR2681322B1 (fr) 1991-09-12 1993-12-17 Laboratorios Dr Esteve Sa Derives d'aryl-heteroaryl-{n-[2-(3,4-dimethoxyphenyl)-ethyl]-n-methyl-3-aminopropoxy}-methane leur preparation et leur application en tant que medicaments .
FR2716883B1 (fr) * 1994-03-04 1996-04-26 Roussel Uclaf Nouveaux dérivés tétrasubstitués de l'imidazole, leur préparation, nouveaux intermédiaires obtenus, leur application à titre de médicaments, compositions pharmaceutiques les renfermant.
JP3311858B2 (ja) 1994-03-08 2002-08-05 四国化成工業株式会社 銅及び銅合金の表面処理剤
DE69823868T2 (de) 1997-12-04 2005-04-21 Allergan Inc Substituierte imidazole derivate mit agonistischähnlicher wirkung auf die alpha 2b oder 2b/2c adrenergischen rezeptoren
US6103733A (en) * 1998-09-09 2000-08-15 Bachmann; Kenneth A. Method for increasing HDL cholesterol levels using heteroaromatic phenylmethanes
TWI283669B (en) 1999-06-10 2007-07-11 Allergan Inc Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors
EP1196452B8 (de) 1999-06-25 2005-08-03 Lanxess Deutschland GmbH Verfahren zur copolymerisation von polaren und unpolaren monomeren
US6951948B2 (en) 2000-06-05 2005-10-04 Ortho-Mcneil Pharmaceutical, Inc. Method for synthesis of substituted azole libraries
TW200306783A (en) 2002-04-29 2003-12-01 Fmc Corp Pesticidal heterocycles
DE10304374A1 (de) 2003-02-04 2004-08-05 Aventis Pharma Deutschland Gmbh Neue substituierte 2-Aminoimidazole, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JP2007500219A (ja) 2003-05-16 2007-01-11 アンビット バイオサイエンシス コーポレーション 複素環化合物およびその使用法
US7812163B2 (en) * 2003-07-16 2010-10-12 Hatchtech Pty Ltd. Methods and compositions for controlling ectoparasites
AU2003903686A0 (en) 2003-07-16 2003-07-31 Hatchtech Pty Ltd Methods and compositions for controlling ectoparasites
RU2375346C2 (ru) * 2003-09-25 2009-12-10 ДОМПЕ ФА.Р.МА С.п.А. Амидины и их производные и содержащие их фармацевтические композиции
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
WO2006119411A1 (en) * 2005-05-03 2006-11-09 Bayer Cropscience Ag Insecticidal substituted aminoalkyl heterocyclic and heteroaryl derivatives
US7592362B2 (en) * 2006-01-19 2009-09-22 Pfizer Limited Substituted imidazoles
JP2009524617A (ja) * 2006-01-27 2009-07-02 エフ．ホフマン−ラ ロシュ アーゲー 置換２−イミダゾール又はイミダゾリン誘導体の使用

Also Published As

Publication number Publication date
MEP4208A (en) 2010-06-10
SI1981853T1 (sl) 2011-08-31
US7544706B2 (en) 2009-06-09
NO341141B1 (no) 2017-08-28
RS53512B1 (en) 2015-02-27
CN101370786A (zh) 2009-02-18
AU2007206698B2 (en) 2011-11-03
US20080125473A1 (en) 2008-05-29
US20070167506A1 (en) 2007-07-19
US20090312326A1 (en) 2009-12-17
KR20080085046A (ko) 2008-09-22
WO2007083207A1 (en) 2007-07-26
MY145812A (en) 2012-04-30
DE602007013869D1 (de) 2011-05-26
EP2423199A1 (en) 2012-02-29
IL192063A0 (en) 2008-12-29
CA2632771A1 (en) 2007-07-26
EA015738B1 (ru) 2011-10-31
US7547718B2 (en) 2009-06-16
CA2632771C (en) 2011-03-22
BRPI0707185B8 (pt) 2021-05-25
PT1981853E (pt) 2011-06-27
KR101044494B1 (ko) 2011-06-27
RS20080304A (en) 2009-05-06
EA200870079A1 (ru) 2009-02-27
AU2007206698A1 (en) 2007-07-26
AR059055A1 (es) 2008-03-12
BRPI0707185B1 (pt) 2020-03-17
ME00044B (me) 2010-06-10
TW200738644A (en) 2007-10-16
NO20083404L (no) 2008-08-04
TNSN08306A1 (fr) 2009-12-29
JP2009528979A (ja) 2009-08-13
CN101370786B (zh) 2012-01-11
MA30166B1 (fr) 2009-01-02
HK1127919A1 (en) 2009-10-09
ATE505461T1 (de) 2011-04-15
US20080119536A1 (en) 2008-05-22
DK1981853T3 (da) 2011-06-20
EP1981853B1 (en) 2011-04-13
US7592362B2 (en) 2009-09-22
PL1981853T3 (pl) 2011-08-31
EP1981853A1 (en) 2008-10-22
CY1111473T1 (el) 2015-08-05
NZ569209A (en) 2010-09-30
US7825149B2 (en) 2010-11-02
TWI337998B (en) 2011-03-01
ES2362935T3 (es) 2011-07-15
UA93696C2 (ru) 2011-03-10
BRPI0707185A2 (pt) 2011-04-26
ZA200805565B (en) 2009-12-30
JP4463317B2 (ja) 2010-05-19

Similar Documents

Publication Publication Date Title
UY30096A1 (es) Imidazoles sustituidos
SV2010003472A (es) Compuestos de pirazol
CO6470826A2 (es) Moduladores de lxr
CR11819A (es) Compuestos de isoindolina 5-sustituidos
CR11229A (es) Pirimidil ciclopentanos como inhibidores de proteina cinasa akt
UY29601A1 (es) Arilpirazoles sustituidos
UY31189A1 (es) Compuestos heterocíclicos
NI201000109A (es) Derivados bis-(sulfonilamino) para uso en terapia.
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
ECSP11011489A (es) Compuestos de triazol que portan un sustituyente de azufre x
CR10712A (es) Derivados de quinazolinona 5-sustituidos como agentes antitumorales
CR20120130A (es) Compuestos de benzoxepina inhibidores de la pi3k y métodos de uso
CO6361936A2 (es) Imidazopiridazinacarbonitrilos utiles como inhibidores de quinasa
AR062875A1 (es) Compuestos de n- metilaminometil isoindol y composiciones que los comprenden y metodos para utilizarlos
SV2009003325A (es) Derivados de imidazol como inhibidores de proteina de huso de cinesina (eg-5)
UY30791A1 (es) Arilpirazoles sustituidos
GT200600117A (es) Nuevos compuestos farmaceuticos
ECSP088265A (es) Derivados de carboxamida como antagonistas del receptor muscarínico
CO6361924A2 (es) Nuevas lactamas como inhibidores de beta secretasa
SV2009003389A (es) Compuestos de pirido [2,3-d] pirimidina-7-ona como inhibidores de p13k-alfa para el tratamiento del cancer
NI201000089A (es) Derivados de pirazol como inhibidores de 5-lo.
NI201100015A (es) Compuestos novedosos activos como antagonistas de receptor muscarínico.
CO6761294A2 (es) Derivados de pirazol que modulan la estearoil-coa-desaturasa
CR20110217A (es) Pirrolidinas
UY31338A1 (es) Compuestos novedosos activos como antagonistas de receptores muscarinicos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20180809